Suresh S Ramalingam Selected Research

acridine yellow

2/2012

Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh S Ramalingam Research Topics

Disease

132	Neoplasms (Cancer) 11/2022 - 06/2007
123	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 06/2007
63	Lung Neoplasms (Lung Cancer) 11/2022 - 11/2010
23	Disease Progression 09/2021 - 11/2008
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020 - 03/2010
8	Adenocarcinoma of Lung 09/2020 - 12/2015
8	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
6	Fatigue 01/2020 - 06/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 09/2014
5	Neutropenia 05/2021 - 08/2017
5	Adenocarcinoma 01/2020 - 05/2011
5	Carcinogenesis 01/2019 - 03/2012
4	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2012
4	Diarrhea 05/2021 - 08/2010
4	Pneumonia (Pneumonitis) 01/2018 - 12/2016
3	Mesothelioma 11/2021 - 09/2008
3	Malignant Mesothelioma 11/2021 - 09/2008
3	Head and Neck Neoplasms (Head and Neck Cancer) 11/2020 - 06/2007
3	Nausea 01/2020 - 01/2010
3	Epilepsy (Aura) 01/2019 - 04/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 03/2014
3	Hypertension (High Blood Pressure) 12/2017 - 08/2010
2	Exanthema (Rash) 01/2022 - 11/2014
2	Respiratory Insufficiency (Respiratory Failure) 05/2021 - 12/2016
2	Dyspnea (Shortness of Breath) 05/2021 - 09/2008
2	Necrosis 01/2021 - 04/2013
2	Hyperglycemia 01/2020 - 12/2014
2	Thrombocytopenia (Thrombopenia) 12/2019 - 06/2012
2	Hyponatremia 12/2019 - 01/2010
2	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

37	ErbB Receptors (EGF Receptor)IBA 10/2021 - 01/2008
36	osimertinibIBA 06/2022 - 04/2015
25	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2008
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
18	Biomarkers (Surrogate Marker)IBA 11/2021 - 06/2012
16	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 06/2007
16	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 06/2007
13	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 09/2008
11	B7-H1 AntigenIBA 01/2022 - 01/2018
11	PlatinumIBA 12/2021 - 01/2008
11	Everolimus FDA Link 10/2020 - 08/2010
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 12/2008
9	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2015
9	NivolumabIBA 01/2022 - 03/2015
9	Pharmaceutical PreparationsIBA 01/2020 - 01/2008
8	LigandsIBA 01/2022 - 08/2011
7	veliparibIBA 11/2021 - 12/2014
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2008
7	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 01/2014
7	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2008
7	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 12/2012
7	Monoclonal AntibodiesIBA 01/2019 - 05/2008
7	TOR Serine-Threonine KinasesIBA 01/2019 - 12/2008
7	Anaplastic Lymphoma KinaseIBA 03/2016 - 04/2012
6	Biological ProductsIBA 01/2022 - 03/2009
6	IpilimumabIBA 01/2022 - 05/2018
6	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2007
5	Pemetrexed (MTA)FDA Link 11/2021 - 09/2008
5	MTOR InhibitorsIBA 02/2021 - 12/2008
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 03/2010
5	Phosphotransferases (Kinase)IBA 12/2019 - 02/2012
5	Sirolimus (Rapamycin)FDA Link 01/2019 - 12/2008
5	Cetuximab (Erbitux)FDA Link 07/2015 - 11/2008
5	Vorinostat FDA Link 10/2010 - 06/2007
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2019
4	pembrolizumabIBA 01/2022 - 02/2018
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2013
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2017
3	AntigensIBA 01/2022 - 06/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
3	AntibodiesIBA 01/2021 - 01/2016
3	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 01/2015
3	Cytotoxins (Cytolysins)IBA 12/2019 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 11/2008
3	human ERBB2 proteinIBA 11/2017 - 03/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015 - 03/2011
3	Histone Deacetylases (Histone Deacetylase)IBA 03/2014 - 09/2008
3	Eukaryotic Initiation Factor-4EIBA 03/2013 - 08/2009
2	durvalumabIBA 11/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021 - 01/2020
2	sotorasibIBA 01/2021 - 01/2020
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2021 - 08/2011
2	NVP-BKM120IBA 01/2020 - 12/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019 - 12/2014
2	Gefitinib (Iressa)FDA Link 01/2019 - 01/2019
2	TensinsIBA 01/2018 - 10/2017
2	Adenosine Monophosphate (AMP)IBA 01/2018 - 11/2014
2	RamucirumabIBA 01/2018 - 04/2016

Therapy/Procedure

84	Therapeutics 10/2021 - 01/2008
36	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
21	Immunotherapy 05/2022 - 01/2015
12	Radiotherapy 11/2019 - 03/2011
4	Precision Medicine 01/2022 - 03/2014
3	Adjuvant Chemotherapy 01/2022 - 03/2016
2	Chemoprevention 11/2020 - 03/2014
2	Salvage Therapy 01/2020 - 03/2013
2	Chemoradiotherapy 01/2019 - 09/2017